Stepanov Alexandr, Codenotti Marco, Ramoni Andrea, Prati Matteo, Jiraskova Nada, Rozsival Pavel, Bandello Francesco
Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove - Czech Republic.
Department of Ophthalmology, Faculty of Medicine University Vita-Salute San Raffaele in Milan and University Hospital San Raffaele in Milan, Milan - Italy.
Eur J Ophthalmol. 2016 Apr 12;26(3):e52-4. doi: 10.5301/ejo.5000715.
Intravitreal implantation of dexamethasone implant (Ozurdex®) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure.
This is a case report of migration of Ozurdex® through basal iridectomy in a pseudophakic patient with iris claw lens.
Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex® into the anterior chamber and development of corneal edema.
玻璃体内植入地塞米松植入物（Ozurdex®）被广泛用于治疗视网膜分支或中央静脉阻塞后的黄斑水肿（ME）、糖尿病性黄斑水肿以及与葡萄膜炎或Irvine-Gass综合征相关的持续性黄斑水肿。我们描述了一种并发症：在一名人工晶状体眼患者中，地塞米松植入物通过基底虹膜切除术（安藤术式）进入前房，导致角膜水肿和继发性高眼压。
这是一例人工晶状体眼且植入虹膜爪状晶状体的患者中Ozurdex®通过基底虹膜切除术移位的病例报告。
有玻璃体切割术史的人工晶状体眼患者，即使是接受过基底虹膜切除术（安藤术式）的患者，Ozurdex®进入前房并导致角膜水肿的风险也很高。
